Topic: To Integrate the TCM in Current Clinical Oncology



The Center for Traditional Chinese Medicine, Inc.
3100 South Tamiami Trail, Sarasota, FL 34239, 1993 – present
President of AnFaLa Pharmaceutical Incorporation, Sarasota, Florida since 2010.
Affiliation Member of H. Lee Moffitt Cancer Center, Tampa, Florida
Doctor of Philosophy (Traditional Chinese Medicine and Pharmacology, Cellular Biology and Immunology, Beijing University of Chinese Medicine and Pharmacology, 1990
Master of Medical Science from Beijing University of Chinese Medicine and Pharmacology, 1987.
Bachelor of Medical Science, Henan College of Traditional Chinese Medicine, 1984
Board Certified Acupuncture Physician since 1993
Diplomat in Chinese Herbology since1993
Honor and Awards
Science and Technology Research Award, 1990, From Beijing University of TCM and Pharmacology
Current Memberships

  1. Affiliation member of H. Lee. Moffitt Cancer Center, Research Institute. Tampa, Florida.
  2. America Association of Acupuncture and Oriental Medicine
  3. Florida State of Oriental Medical Association


Modern clinical oncology has advanced tremendously over the past five years. There is not much room left for TCM in the clinical oncological practice, especially in North American. It is necessary to integrate the TCM into this field, which will help TCM to earn the respect in treating chronic and severe diseases and bring more benefit for cancer patients. TCM has its own advantage in handling cancer patients.
To help patient reach earlier diagnosis as possible. We must re-educate patients and colleagues to encourage cancer patients to get acupuncture treatment as soon as possible. To increase the patient’s heart Yang Qi, calm down patient’s mind; to guarantee the energy movement smoothly in all meridians and maintain the five organs function properly. To unblock the septa between the tumor related immunity and the general immune system. With the acupuncture and herbal medicine combination, the tumor environment can be modified and epigenetic condition. To reduce the side effect from chemotherapy and radiation therapy. To build up a strong platform for targeting drug and immunotherapy to play their best roles.


Only Alliance Members or Conference Register Members could access the video recording, if you are a member please login to watch it, if you are not a member yet please sign up. St Mary’s Road, Winnipeg, MB, R3C 1L7

Copyright 2022 AACMC © All rights reserved. Develop by AT-Digital